AOD 9604 5mg What is AOD 9604
Products sold as DSIP are research chemicals, and there are no validated dosing guidelines, so sourcing risk is significant
This titration approach has proven essential for treatment adherence and participant comfort
Acknowledgments The authors would like to thank Aouatef Bellamine, for her help with study management and Suzanne Morris, at Concrete Medical Writing, LLC, for providing medical writing support (funded by Lonza)
Summary Keywords molecular screening, bilirubin, favism, hemolytic anemia, neonatal jaundice, peroxiredoxin 2, Heinz bodies, G6PD Citation Lee HY, Ithnin A, Azma RZ, Othman A, Salvador A and Cheah FC (2022) Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Hyperbilirubinemia: Insights on Pathophysiology, Diagnosis, and Gene Variants in Disease Heterogeneity